Sign In
Buy LLY
$1,169.86
+53.75 (+4.82%)
At Close: Aug 05, 2026
Philippe Laffont's Strategic Moves: CoreWeave Inc Faces a -5.03% Portfolio Impact
04:01pm, Friday, 14'th Nov 2025
Exploring the Latest 13F Filing and Investment Adjustments Introduction to Philippe Laffont (Trades, Portfolio) and Coatue Management Philippe Laffont (Trades,
Chase Coleman's Strategic Moves: Meta Platforms Inc. Sees Significant Reduction
03:04pm, Friday, 14'th Nov 2025
Exploring the Third Quarter 2025 13F Filing of Tiger Global Management Chase Coleman (Trades, Portfolio) recently submitted the 13F filing for the third quarte
Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since
01:02pm, Friday, 14'th Nov 2025
The world's most valuable healthcare stock, Eli Lilly and Company NYSE: LLY, just dropped huge news. Like Pfizer NYSE: PFE, Lilly announced a drug pricing deal with the Trump Administration.
Eli Lilly Leads Three Stocks Near Buy Points
12:56pm, Friday, 14'th Nov 2025
Eli Lilly stock hit an all-time high in Friday's stock market.
Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance?
10:02am, Friday, 14'th Nov 2025
Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing weight-loss market.
Health Rounds: Lilly blood thinner tops AstraZeneca's for heart procedure patients with diabetes
07:06am, Friday, 14'th Nov 2025
Blood-thinning drugs that doctors often prescribe interchangeably after procedures to reopen narrowed heart arteries don't work equally well in patients with diabetes, a study from India found.
It Looks Like Eli Lilly Will Become The Next Trillion Dollar Baby
02:22am, Friday, 14'th Nov 2025
Eli Lilly is poised to become the first $1 trillion pharmaceutical company, driven by explosive growth in its weight-loss drug, Mounjaro. LLY's earnings and sales growth have been exceptional, with qu
Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs
02:04pm, Thursday, 13'th Nov 2025
Novo Nordisk and Eli Lilly do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc , spokespeople for both companies said, rejecting a press release issued by the company
Can Equities Stabilize after the Government Reopens?
01:51pm, Thursday, 13'th Nov 2025
As traders position for year-end, the government shutdown is over, major market indices are filling gaps, and seasonal momentum looms.
Jefferies Group's Strategic Move: Vanguard Information Technology ETF Takes Center Stage
11:03am, Thursday, 13'th Nov 2025
Jefferies Group (Trades, Portfolio)'s Latest 13F Filing Reveals Strategic Portfolio Adjustments Jefferies Group (Trades, Portfolio) recently submitted its 13F
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs
07:15am, Thursday, 13'th Nov 2025
Telehealth company Mangoceuticals said on Thursday it has partnered with Eli Lilly and Novo Nordisk to sell the drugmakers' blockbuster weight-loss drugs through its platform.
1 Incredible Reason to Buy LLY's Stock in November
04:25am, Thursday, 13'th Nov 2025
Eli Lilly is the market-share leader for weight-loss drugs. Coverage by government insurance programs is a huge win for the company.
Bitget Lists LLY, MA, UNH Stock Index Perpetual Futures as Cumulative Trading Volume on Bitget hits $3 Billion
01:17am, Thursday, 13'th Nov 2025
VICTORIA, Seychelles, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), has announced the official addition of LLYUSDT, MAUSDT, UNHUSDT stock index perpetual futu
MeiraGTx: Latest Eli Lilly Partnership Ignites Riboswitch Technology Potential
03:30pm, Wednesday, 12'th Nov 2025
MeiraGTx Holdings plc secures a transformative partnership with Eli Lilly, granting worldwide rights to its AAV-AIPL1 gene therapy for LCA4. MGTX receives $75 million upfront, up to $400 million in mi
Eli Lilly Stock: This Trade On The Rising Stock Holds $1,415 In Profit Potential
11:42am, Wednesday, 12'th Nov 2025
Eli Lilly's strong price action and high ratings present a bull call spread trading opportunity with large profit potential and clearly defined risk parameters.
